Back to search
FDAFDA · Food and drugs·Recall number D-0388-2022

Mucus Relief D, Guaifenesin Pseudoephedrine HCl ER Tablets, 600 mg/60mg, packaged in 36-count blister pack packed into cartons, Distributed by: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015, Made in India, NDC 0363-164-3

Published January 26, 2022 · Recall initiated: January 10, 2022

Summary

FDA records drug Class III recall D-0388-2022, published January 26, 2022 and initiated January 10, 2022. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 18336 cartons; Lot: Lot #: AT2102065A, AT2102065B, Exp 04/2023. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent drug

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
USA Nationwide
Lot
Lot #: AT2102065A, AT2102065B, Exp 04/2023.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Mucus Relief D, Guaifenesin Pseudoephedrine HCl ER Tablets, 600 mg/60mg, packaged in 36-count blister pack packed into cartons, Distributed by: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015, Made in India, NDC 0363-164-3 recalled?

Yes. FDA published recall D-0388-2022 on January 26, 2022. Reported hazard: Subpotent drug

What should I do if I have this product?

Voluntary: Firm initiated · Letter